
neck malignancy is different from that of the typical atherosclerotic population. There is a higher incidence of diffuse
disease, often involving the CCA, and many of these patients remain neurologically asymptomatic. Further, CEA
in this group is considered relatively “high risk,” and prior
radiotherapy is a relative indication for CAS rather than
CEA. There are no robust data on the long-term results of
CAS in asymptomatic stenosis associated with